Fundraising FoxPBM Capital — Full Portfolio
7 tracked investments · listed companies and verified rows first
Liquidia develops and commercializes inhaled and injectable therapies for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
BiotechMorrisville, US
Damian deGoa(Executive Officer, Director)inMichael Kaseta(Executive Officer)in
BoardStephen Bloch(Director)inJoanna Horobin(Director)Raman Singh(Director)
Board seatPaul B. Manning· per SEC Form D · $21.7M raise · filed Apr 2021
Co-investorsCanaan PartnersNew Enterprise Associates (NEA)Xeraya Capital
Taysha Gene Therapies develops and commercializes gene therapies for monogenic diseases of the central nervous system, serving patients with rare and larger CNS conditions.
BiotechDeep TechDigital HealthHealthtechMedical DevicesTexas, US
R.A. Session II(Executive Officer, Director)inSean P. Nolan(Chief Executive Officer and Board Chairman)in
Board seatPaul B. Manning· per SEC Form D · $30M raise · filed Nov 2022
Co-investorsGV (Google Ventures)BairdGoldman SachsJefferies
Verrica Pharmaceuticals is a therapeutics company developing and commercializing treatments for dermatological diseases, including molluscum contagiosum, common warts, and skin cancers such as basal cell and squamous cell carcinoma.
BiotechHealthtechMedical DevicesWest Chester, US
Noah Rosenberg(Executive Officer)inJohn Kirby(Executive Officer)Matthew Davidson(Executive Officer, Director)
BoardDavid Zawitz(Executive Officer)
Board seatPaul B. ManningJayson Rieger· per SEC Form D
Co-investorsOrbiMed
HealthtechBoulder, US
Jason Myers(Executive Officer, Director)Christian LaPointe(Executive Officer)
BoardKyle Lefkoff(Director)inPaul Manning(Director)in
Board seatPaul B. Manning· per SEC Form D
Co-investorsCrawley VenturesBoulder VenturesLongwood FundREDMILESands Capital VenturesSoleus Capital
BiotechCharlottesville, US
Raymond Chavez(Executive Officer, Director)inStephen Collins(Executive Officer, Director)inLinda Watkins(Director)
BoardPeter Heinecke(Director)John Forsayeth(Director)
Board seatPaul B. ManningJayson Rieger· per SEC Form D · $30M raise · filed Jun 2021
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.